Civic Intelligence

Open Biopharma Training Institute Inc.

990EZ • Fiscal year 2022 • EIN 84-2113756

Apr 01, 2021 to Mar 31, 2022 • Filed on Mar 28, 2024

1958 Kellogg AveCarlsbad, CA 92008

(949) 378-5072

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

89th percentile

0.42x

Higher debt load relative to assets than 89% of similar nonprofits.

2022 filings • 501(c)3 • <$500k nonprofits • Source year 2022

Liabilities / Revenue

89th percentile

0.29x

Higher debt load relative to revenue than 89% of similar nonprofits.

2022 filings • 501(c)3 • <$500k nonprofits • Source year 2022

Net Margin

80th percentile

31%

Higher net margin than 80% of similar nonprofits.

2022 filings • 501(c)3 • <$500k nonprofits • Source year 2022

Top Officer Pay

78th percentile

$0

Higher top officer pay than 78% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2022 filings • 501(c)3 • <$500k nonprofits • Source year 2022

Asset Growth

98th percentile

557%

Faster asset growth than 98% of similar nonprofits.

2022 filings • 501(c)3 • <$500k nonprofits • Annualized from 2021 to 2022

Revenue Growth

97th percentile

838%

Faster revenue growth than 97% of similar nonprofits.

2022 filings • 501(c)3 • <$500k nonprofits • Annualized from 2021 to 2022

Assets

Up

$42,737

Up $36,237 (+557%) from 2021

Net Assets

Up

$24,997

Up $18,964 (+314%) from 2021

Liabilities

Up

$17,740

Up $17,273 (+3699%) from 2021

Revenue

Up

$61,000

Up $54,500 (+838%) from 2021

Expenses

Up

$42,036

Up $41,569 (+8901%) from 2021

Net Income

Up

$18,964

Up $12,931 (+214%) from 2021

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2020: $1Liabilities 2020: $02020Assets 2021: $6,500Liabilities 2021: $467Net Assets 2021: $6,0332021Assets 2022: $42,737Liabilities 2022: $17,740Net Assets 2022: $24,9972022Assets 2023: $15,773Liabilities 2023: $6,261Net Assets 2023: $9,5122023Assets 2025: $231,411Liabilities 2025: $27,791Net Assets 2025: $203,6202025

Highlighted filing

2022

Assets$42,737
Liabilities$17,740
Net Assets$24,997

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KRevenue 2020: $0Expenses 2020: $0Net Income 2020: $02020Revenue 2021: $6,500Expenses 2021: $467Net Income 2021: $6,0332021Revenue 2022: $61,000Expenses 2022: $42,036Net Income 2022: $18,9642022Revenue 2023: $83,941Expenses 2023: $99,426Net Income 2023: -$15,4852023Revenue 2025: $1,098,841Expenses 2025: $901,591Net Income 2025: $197,2502025

Highlighted filing

2022

Revenue$61,000
Expenses$42,036
Net Income$18,964
Jump To
Filing Snapshot
Filing Period
Apr 1, 2021 to Mar 31, 2022
Signed
Mar 28, 2024
Return Version
2021v4.0
Gross Receipts
$61,000
Mission and Program Overview

Mission

Training and educating biotech industry professionals, employees, students, and military veterans seeking employment in the biotech sector is the primary activity of open biopharma training institute inc. This training will familiarize trainees with the latest biotech processes and equipment and expose them to current research theories and projects. Secondarily - providing access to equipment, systems, and resources for startups, middle-sized companies, and research partners is another activity of open biopharma. The goal here is to foster and assist biotech companies in survival between their startup and phase iii clinical trials and to partner with other researchers in furthering viable solutions to disease diagnosis, prevention, control, and treatment.

Training and educating biotech industry professionals, employees, students, and military veterans seeking employment in the biotech sector is the primary activity of open biopharma training institute inc. This training will familiarize trainees with the latest biotech processes and equipment and expose them to current research theories and projects. Secondarily - providing access to equipment, systems, and resources for startups, middle-sized companies and research partners is another activity of open biopharma.the goal here is to foster and assist biotech companies in survival between their startup and phase iii clinical trials and to partner with other researchers in furthering viable solutions to disease diagnosis, prevention, control, and treatment.

Program Services

DescriptionGrantsExpenses
CIRM TRAINING WAS PROVIDED TO STUDENTS FROM CALIFORNIA STATE UNIVERSITY SAN MARCOS (CSUSM), AND SAN DIEGO STATE UNIVERSITY (SDSU).-$37,936
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
SUSAN SZATHMARY MD PHDPresident Di-$0--
MARCO F GARAVAGLIA ESQTreasurer Di-$0--
WILLIAM RANDALL ALMS CPACFO Director-$0--
Filing and Contact Details

Filer

Filer Name
Open Biopharma Training Inst Inc
EIN
84-2113756
Phone
9493785072
Address
1958 KELLOGG AVE, CARLSBAD, CA 92008

Signing Officer

Name
William Randall Alms CPA
Title
CFO Director
Phone
9493785072
Signed
2024-03-28
Discuss with paid preparer
Yes

Preparer

Firm
W Randall Alms CPA
Address
5558 NANDAY CT, OCEANSIDE, CA 92057
Preparer
W Randall Alms
Phone
9493785072
Supplemental Narrative

Additional Explanations

Form 990-ez, Part II, Line 24

Accounts receivable 0 3,000 total 0 3,000

Form 990-ez, Part II, Line 26

Accounts payable and accrued expenses 467 17,740

Form 990-ez, Part III

Training and educating biotech industry professionals, employees, students, and military veterans seeking employment in the biotech sector is the primary activity of open biopharma training institute inc. This training will familiarize trainees with the latest biotech processes and equipment and expose them to current research theories and projects. Secondarily - providing access to equipment, systems, and resources for startups, middle-sized companies and research partners is another activity of open biopharma.the goal here is to foster and assist biotech companies in survival between their startup and phase iii clinical trials and to partner with other researchers in furthering viable solutions to disease diagnosis, prevention, control, and treatment.

Raw XML Appendix126 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0WILLIAM RANDALL ALMS CPA
IRS990EZ/BooksInCareOfDetail/PhoneNum09493785072
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt05558 NANDAY COURT
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0OCEANSIDE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092057
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt06500
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt039737
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt02500
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt018964
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt042036
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt06500
IRS990EZ/Form990TotalAssetsGrp/EOYAmt042737
IRS990EZ/GrossReceiptsAmt061000
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt06033
IRS990EZ/NetAssetsOrFundBalancesEOYAmt024997
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt06033
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt024997
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0SUSAN SZATHMARY MD PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1MARCO F GARAVAGLIA ESQ
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2WILLIAM RANDALL ALMS CPA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT DI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1TREASURER DI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2CFO DIRECTOR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/EOYAmt03000
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0TRAINING AND EDUCATING BIOTECH INDUSTRY PROFESSIONALS, EMPLOYEES, STUDENTS, AND MILITARY VETERANS SEEKING EMPLOYMENT IN THE BIOTECH SECTOR IS THE PRIMARY ACTIVITY OF OPEN BIOPHARMA TRAINING INSTITUTE INC. THIS TRAINING WILL FAMILIARIZE TRAINEES WITH THE LATEST BIOTECH PROCESSES AND EQUIPMENT AND EXPOSE THEM TO CURRENT RESEARCH THEORIES AND PROJECTS. SECONDARILY - PROVIDING ACCESS TO EQUIPMENT, SYSTEMS, AND RESOURCES FOR STARTUPS, MIDDLE-SIZED COMPANIES AND RESEARCH PARTNERS IS ANOTHER ACTIVITY OF OPEN BIOPHARMA.THE GOAL HERE IS TO FOSTER AND ASSIST BIOTECH COMPANIES IN SURVIVAL BETWEEN THEIR STARTUP AND PHASE III CLINICAL TRIALS AND TO PARTNER WITH OTHER RESEARCHERS IN FURTHERING VIABLE SOLUTIONS TO DISEASE DIAGNOSIS, PREVENTION, CONTROL, AND TREATMENT.
IRS990EZ/ProgramServiceRevenueAmt058500
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0CIRM TRAINING WAS PROVIDED TO STUDENTS FROM CALIFORNIA STATE UNIVERSITY SAN MARCOS (CSUSM), AND SAN DIEGO STATE UNIVERSITY (SDSU).
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt037936
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt0467
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt017740
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt042036
IRS990EZ/TotalProgramServiceExpensesAmt037936
IRS990EZ/TotalRevenueAmt061000
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.OPENBIOPHARMA.ORG
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt02500
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt06500
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt09000
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt058500
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt058500
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt067500
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt061000
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt06500
IRS990ScheduleA/Total509Grp/TotalAmt067500
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt061000
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt06500
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt067500
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0ACCOUNTS RECEIVABLE 0 3,000 TOTAL 0 3,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ACCOUNTS PAYABLE AND ACCRUED EXPENSES 467 17,740
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2TRAINING AND EDUCATING BIOTECH INDUSTRY PROFESSIONALS, EMPLOYEES, STUDENTS, AND MILITARY VETERANS SEEKING EMPLOYMENT IN THE BIOTECH SECTOR IS THE PRIMARY ACTIVITY OF OPEN BIOPHARMA TRAINING INSTITUTE INC. THIS TRAINING WILL FAMILIARIZE TRAINEES WITH THE LATEST BIOTECH PROCESSES AND EQUIPMENT AND EXPOSE THEM TO CURRENT RESEARCH THEORIES AND PROJECTS. SECONDARILY - PROVIDING ACCESS TO EQUIPMENT, SYSTEMS, AND RESOURCES FOR STARTUPS, MIDDLE-SIZED COMPANIES AND RESEARCH PARTNERS IS ANOTHER ACTIVITY OF OPEN BIOPHARMA.THE GOAL HERE IS TO FOSTER AND ASSIST BIOTECH COMPANIES IN SURVIVAL BETWEEN THEIR STARTUP AND PHASE III CLINICAL TRIALS AND TO PARTNER WITH OTHER RESEARCHERS IN FURTHERING VIABLE SOLUTIONS TO DISEASE DIAGNOSIS, PREVENTION, CONTROL, AND TREATMENT.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART II, LINE 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
ReasonableCauseExplanation/ExplanationTxt0DIAGNOSIS AND TREATMENT OF A MAJOR ILLNESS IN A DIRECTOR AND PRESSING BUSINESS DEMANDS RESULTED IN THE FILING OF THIS RETURN BEYOND THE EXTENDED DUE DATE. WE RESPECTFULLY REQUEST THAT ANY PENALTIES BE WAIVED.
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0WILLIAM RANDALL ALMS CPA
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CFO DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum09493785072
ReturnHeader/BusinessOfficerGrp/SignatureDt02024-03-28
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0OPEN BIOPHARMA TRAINING INST INC
ReturnHeader/Filer/BusinessNameControlTxt0OPEN
ReturnHeader/Filer/EIN0842113756
ReturnHeader/Filer/PhoneNum09493785072
ReturnHeader/Filer/USAddress/AddressLine1Txt01958 KELLOGG AVE
ReturnHeader/Filer/USAddress/CityNm0CARLSBAD
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092008
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0274540636
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0W RANDALL ALMS CPA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt05558 NANDAY CT
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0OCEANSIDE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092057
ReturnHeader/PreparerPersonGrp/PhoneNum09493785072
ReturnHeader/PreparerPersonGrp/PreparationDt02024-03-28
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0W RANDALL ALMS
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02024-03-28T22:12:21-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0WILLIAM R
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0ALMS
ReturnHeader/TaxPeriodBeginDt02021-04-01
ReturnHeader/TaxPeriodEndDt02022-03-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings